Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Sep. 30, 2015
Sep. 30, 2014
REVENUES    
Neurometric Services $ 100,100 $ 135,100
OPERATING EXPENSES    
Cost of neurometric service revenues 4,900 73,000
Research 92,000 116,200
Product development 691,800 1,338,500
Sales and marketing 347,900 390,200
General and administrative 1,619,900 2,034,000
Total operating expenses 2,756,500 3,951,900
OPERATING LOSS (2,656,400) (3,816,800)
OTHER INCOME (EXPENSE)    
Interest expense, net (257,400) (11,700)
Gain (Loss) on extinguishment of debt $ (630,000) 1,105,200
Financing fees (1,800)
Gain on derivative liabilities $ 162,800 26,100
Other miscellaneous income - write backs 44,100
Total other income (expense) $ (724,600) 1,161,900
LOSS BEFORE PROVISION FOR INCOME TAXES (3,381,000) (2,654,900)
Provision for income taxes 5,000 5,200
LOSS FROM CONTINUING OPERATIONS (3,386,000) (2,660,100)
Gain (Loss) from discontinued operations 6,600 (2,700)
NET LOSS $ (3,379,400) $ (2,662,800)
BASIC AND DILUTED NET LOSS PER SHARE    
From continuing operations (in dollars per share) $ (0.03) $ (0.03)
From discontinued operations (in dollars per share) (0.00) (0.00)
Combined Net Loss (in dollars per share) $ (0.03) $ (0.03)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
Basic and diluted (in shares) 101,813,242 99,326,519